GENOVIS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.8 SEK | -2.03% |
|
+12.29% | -35.00% |
| 05-15 | Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-14 | Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 36.20 | 36.20 | 39.00 |
| Spread/Res. | -6.63% | -6.63% | -13.33% |
| Spread/Supp. | +30.25% | +30.25% | +20.28% |
| Support | 25.95 | 25.95 | 28.10 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- GENO Stock
- Charts Genovis AB
